On 2025-03-11, Bioventus Inc. (BVS) announced earnings per share of $0.15 for the fiscal quarter ending 2024-12-31, beating the average analyst estimate of $0.09.
The next expected annoucement date for quarterly earnings is 2025-05-06, with an average estimated earnings per share of $0.06 for the fiscal quarter ending 2025-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-03-11 | 2024-12-31 | $0.09 | $0.15 |
| 2024-11-05 | 2024-09-30 | $0.06 | $0.06 |
| 2024-08-06 | 2024-06-30 | $0.07 | $0.19 |
| 2024-05-07 | 2024-03-31 | $-0.05 | $0.07 |
| 2024-03-12 | 2023-12-31 | $0.06 | $0.07 |
| 2023-11-07 | 2023-09-30 | $0.06 | $0.05 |
| 2023-08-08 | 2023-06-30 | $0.03 | $0.14 |
| 2023-05-16 | 2023-03-31 | $-0.11 | $-0.26 |
| 2023-03-31 | 2022-12-31 | $0.05 | $-0.06 |
| 2022-11-21 | 2022-09-30 | $0.13 | $0.05 |
| 2022-08-11 | 2022-06-30 | $0.14 | $0.10 |
| 2022-05-10 | 2022-03-31 | $0.01 | $0.04 |
| 2022-03-10 | 2021-12-31 | $0.20 | $0.26 |
| 2021-11-09 | 2021-09-30 | $0.13 | $0.25 |
| 2021-08-10 | 2021-06-30 | $0.10 | $0.16 |
| 2021-05-12 | 2021-03-31 | $0.04 | $-0.02 |
| 2021-03-25 | 2020-12-31 | -- | $2.32 |